Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.

Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone?

Open access
Girgis, Christian M., Mokbel, Nancy, DiGirolamo, Douglas J. · 2014 · Current Osteoporosis Reports

Abstract

Musculoskeletal diseases are highly prevalent with staggering annual health care costs across the globe. The combined wasting of muscle (sarcopenia) and bone (osteoporosis)-both in normal aging and pathologic states-can lead to vastly compounded risk for fracture in patients. Until now, our therapeutic approach to the prevention of such fractures has focused solely on bone, but our increasing understanding of the interconnected biology of muscle and bone has begun to shift our treatment paradigm for musculoskeletal disease. Targeting pathways that centrally regulate both bone and muscle (eg, GH/IGF-1, sex steroids, etc.) and newly emerging pathways that might facilitate communication between these 2 tissues (eg, activin/myostatin) might allow a greater therapeutic benefit and/or previously unanticipated means by which to treat these frail patients and prevent fracture. In this review, we will discuss a number of therapies currently under development that aim to treat musculoskeletal disease in precisely such a holistic fashion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11914-014-0204-5

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 133 references

Cited by

See all 110

Metadata

Authors
Girgis, C. M., Mokbel, N., & DiGirolamo, D. J.
Affiliations
  • The University of Sydney (AU)
  • Garvan Institute of Medical Research (AU)
  • Johns Hopkins University (US)
Corresponding author
Girgis, Christian M.
Venue
Current Osteoporosis Reports
Published
2014-03-16
Volume
12
Issue
2
Pages
142-153
ISSN
  • 1544-1873 (ISSN-L)
  • 1544-2241
OpenAlex
W1988354324
Cited by
110
References
133
Citations by year
2026: 4 · 2025: 10 · 2024: 11 · 2023: 10 · 2022: 16 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 5 · 2015: 8
FWCI
1.27
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Osteoporosis Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Eli Lilly and Company
  • Royal Australasian College of Physicians
  • National Institutes of Health
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR062074)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
musculoskeletal disorders, sarcopenia, osteoporosis, fracture prevention, muscle-bone crosstalk, myostatin, activin, growth hormone/IGF-1 axis, sex steroids, frailty, therapeutic target
MeSH terms
Acetamides, Amides, Aminophenols, Androgens, Anilides, Antibodies, Exercise Therapy, Hormones, Humans, Osteoporosis, Growth Hormone-Releasing Hormone, Vitamin D, Human Growth Hormone, Bone Density Conservation Agents, Fractures, Bone, Sarcopenia, Osteoporotic Fractures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone? https://app.cochat.ai/papers/10.1007/s11914-014-0204-5
The paper
Girgis, C. M., Mokbel, N., & DiGirolamo, D. J. (2014). Therapies for Musculoskeletal Disease: Can we Treat Two Birds with One Stone? Current Osteoporosis Reports. https://doi.org/10.1007/s11914-014-0204-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.